Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest QuantiFERON Stories

2014-03-20 04:21:53

BEIJING and HILDEN, Germany, March 20, 2014 /PRNewswire/ -- - QuantiFERON-TB, the leading modern test for accurate diagnosis of latent tuberculosis infections, continues to grow rapidly around the world - Commercial launch of QuantiFERON-TB in China, where latent TB affects an estimated 41% of population, will support nationwide efforts to control TB - QIAGEN marks World TB Day 2014 on March 24 with QuantiFERON-TB...

2013-11-19 23:30:30

With the current shortage of TB skin tests, customers can order TB blood testing from Request A Test as an alternative. Brecksville, OH (PRWEB) November 19, 2013 Request A Test, a leading national provider of direct to consumer lab testing, is currently offering the QuantiFERON Gold blood test for Tuberculosis (TB). A Recent shortage of materials needed to perform Tuberculosis skin tests has led to many people and companies not being able to get the testing they need. The Center for...

2013-08-21 23:01:49

More than 20,000 people in Pakistan are being tested for the potentially deadly stage of tuberculosis using a new strategy developed at UC Davis Health System to effectively detect the disease in children for the first time. Sacramento, CA (PRWEB) August 21, 2013 More than 20,000 people in Pakistan are being tested for the potentially deadly stage of tuberculosis using a new strategy developed at UC Davis Health System to effectively detect the disease in children for the first time. At...

2013-08-21 14:28:27

More than 20,000 people in Pakistan are being tested for the potentially deadly stage of tuberculosis using a new strategy developed at UC Davis Health System to effectively detect the disease in children for the first time. At least 600 million people in Pakistan, India and Bangladesh are infected with the tuberculosis bacterium Mycobacterium tuberculosis.  Each year at least three million people reach the potentially deadly stage called active TB. The condition is treatable with...

2013-03-01 23:00:55

Save $10 when ordering Tuberculosis testing from Request A Test. Early diagnosis through lab testing is the key to keeping this infectious disease from spreading. Offer expires 3/31/13. Brecksville, OH (PRWEB) March 01, 2013 This March, Request A Test, a leading national provider of direct to consumer lab testing, is offering $10 off of lab testing for Tuberculosis. To take advantage of this discount, patients just need to use promo code TBTEST10 when placing their order. Many Americans...

2012-01-09 01:00:00

HILDEN and BERLIN, Germany, January 9, 2012 /PRNewswire/ -- - Collaboration to create molecular test assessing a person's risk for latent TB progressing to active TB, enabling early treatment and disease outbreak prevention - QIAGEN strengthening its leading infectious disease portfolio with development of DNA-/RNA-based test that complements QuantiFERON-TB Gold test for latent TB - New assay will use whole blood...

2011-12-10 01:17:10

In populations with a low prevalence of tuberculosis (TB), the majority of positives with the three tests commercially available in the U.S for the diagnosis of TB are false positives, according to a new study. "We compared commercially available tests for latent tuberculosis infection (LTBI) in a diverse population with a low LTBI prevalence," said James Mancuso, MD, DrPH, of the Walter Reed Army Institute of Research Preventive Medicine Residency Program. "Our results suggest that in...

2011-09-14 12:00:00

Cellestis has launched the TB Operation Support Solution (TBoss), a comprehensive service to help support U.S. public health officials in the management of TB contact investigations through the use of QuantiFERON®-TB Gold (QFT®), an interferon gamma release assay (IGRA) approved by the FDA as an in vitro diagnostic aid for the detection of TB infection. Valencia, CA (PRWEB) September 14, 2011 Tuberculosis (TB) is a highly contagious and potentially fatal disease affecting more than...

2011-08-29 00:41:00

VENLO, The Netherlands and MELBOURNE, Australia, August 29, 2011 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that its acquisition of all the ordinary shares in Cellestis Limited ("Cellestis") by a way of a scheme of arrangement ("Scheme") has been implemented. The closing of the transaction follows the official approval of Cellestis' shareholders and Australian courts. QIAGEN had announced the initial proposal to acquire...

2011-08-10 18:15:52

Press release from PLoS Medicine Despite being widely available for sale in low-and-middle income countries, commercial serological tests used to detect active tuberculosis (by identifying antibodies to the tuberculosis-causing bacterium in a blood sample) do not accurately diagnose TB and, furthermore, often test positive when the patient does not have TB (false positive) and test negative when the patient actually has TB (false negative). In addition, as shown in India, the use of such...